Growth hormone secretion

pathway activity — cross-omics
GO:0030252Cross-omicsPROTEIN-MS → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Growth hormone secretion pathway is significantly associated with the protein abundance of multiple proteins, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are CDK16, SHANK2_S877, and MORC2_S743, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Growth hormone secretion activity versus CDK16 in OV (Pearson r = 0.44).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVCDK16 →+0.378+0.630<.001<.00134
GBMSHANK2_S877 →+0.591+0.875.001.00233
GBMMORC2_S743 →+0.418+0.732<.001.00133
GBMBUD13_S271 →+0.689+0.711<.001<.00133
GBMEIF5B_S182 →+1.243+0.904<.001.00233
BRCACDK16_S138 →+0.655+0.694<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0030252 vs CDK16 — OV

Per-sample scatter of Growth hormone secretion activity vs CDK16 in OV.

Explore this scatter interactively →

Exploration